drugset / Trial / NCT01034774
Phase 1 Study to Determine Safety, Blood PK and Lung Penetration
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Multiple center, double-blind, randomized, placebo-controlled study to see if it is safe to give ACHN-490 Injection for 5 consecutive days, to measure plasma pharmacokinetics, and to determine lung penetration of ACHN-490 (measured in ELF-epithelial lining fluid)after a single dose of ACHN-490 Injection in healthy volunteers.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-06
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | plazomicin | Small molecule | 15 mg/kg | Intravenous |
Indications
No indication recorded.